Skip to main content
Erschienen in: European Journal of Clinical Microbiology & Infectious Diseases 10/2012

01.10.2012 | Article

True bacteremias caused by coagulase negative Staphylococcus are difficult to distinguish from blood culture contaminants

verfasst von: M. Rahkonen, S. Luttinen, M. Koskela, T. Hautala

Erschienen in: European Journal of Clinical Microbiology & Infectious Diseases | Ausgabe 10/2012

Einloggen, um Zugang zu erhalten

Abstract

Our aim was to test whether or not true bloodstream infections (BSI) caused by coagulase negative Staphylococci (CoNS) can be distinguished from blood culture contaminants based on simple clinical and laboratory parameters. Patients with blood cultures positive for CoNS (n = 471) were categorized into community acquired infection (CAI), hospital acquired infection (HAI), infections in patients with haematological conditions (HAEI), or culture contaminants (CON) based on the judgement of a clinician. The cases were further analyzed according to widely accepted criteria for true BSI and whether or not vancomycin treatment was initiated. Simple clinical and laboratory parameters, surgical procedures, mortality, central venous catheters, and other foreign materials were registered. Our study demonstrates that the decision about the significance of positive blood culture finding made by the clinician may differ from that indicated by accepted criteria for BSI. Simple clinical findings such as heart rate, body temperature, or systolic blood pressure may not distinguish a culture contaminant from true infections. In addition, the laboratory parameters were surprisingly similar in the different patient cohorts. A blood culture positive for CoNS remains a clinical challenge; our study demonstrates that judging the significance of the finding is difficult.
Literatur
1.
Zurück zum Zitat Weinstein MP, Towns ML, Quartey SM, Mirrett S, Reimer LG, Parmigiani G, Reller LB (1997) The clinical significance of positive blood cultures in the 1990s: a prospective comprehensive evaluation of the microbiology, epidemiology, and outcome of bacteremia and fungemia in adults. Clin Infect Dis 24:584–602PubMed Weinstein MP, Towns ML, Quartey SM, Mirrett S, Reimer LG, Parmigiani G, Reller LB (1997) The clinical significance of positive blood cultures in the 1990s: a prospective comprehensive evaluation of the microbiology, epidemiology, and outcome of bacteremia and fungemia in adults. Clin Infect Dis 24:584–602PubMed
2.
Zurück zum Zitat Kumar A, Roberts D, Wood KE, Light B, Parrillo JE, Sharma S, Suppes R, Feinstein D, Zanotti S, Taiberg L, Gurka D, Kumar A, Cheang M (2006) Duration of hypotension before initiation of effective antimicrobial therapy is the critical determinant of survival in human septic shock. Crit Care Med 34:1589–1596PubMedCrossRef Kumar A, Roberts D, Wood KE, Light B, Parrillo JE, Sharma S, Suppes R, Feinstein D, Zanotti S, Taiberg L, Gurka D, Kumar A, Cheang M (2006) Duration of hypotension before initiation of effective antimicrobial therapy is the critical determinant of survival in human septic shock. Crit Care Med 34:1589–1596PubMedCrossRef
3.
Zurück zum Zitat Varpula M, Karlsson S, Parviainen I, Ruokonen E, Pettilä V (2007) Community-acquired septic shock: early management and outcome in a nationwide study in Finland. Acta Anaesthesiol Scand 51:1320–1326PubMedCrossRef Varpula M, Karlsson S, Parviainen I, Ruokonen E, Pettilä V (2007) Community-acquired septic shock: early management and outcome in a nationwide study in Finland. Acta Anaesthesiol Scand 51:1320–1326PubMedCrossRef
4.
Zurück zum Zitat von Eiff C, Peters G, Heilmann C (2002) Pathogenesis of infections due to coagulase-negative Staphylococci. Lancet Infect Dis 2:677–685CrossRef von Eiff C, Peters G, Heilmann C (2002) Pathogenesis of infections due to coagulase-negative Staphylococci. Lancet Infect Dis 2:677–685CrossRef
5.
Zurück zum Zitat Doern GV, Vautour R, Gaudet M, Levy B (1994) Clinical impact of rapid in vitro susceptibility testing and bacterial identification. J Clin Microbiol 32:1757–1762PubMed Doern GV, Vautour R, Gaudet M, Levy B (1994) Clinical impact of rapid in vitro susceptibility testing and bacterial identification. J Clin Microbiol 32:1757–1762PubMed
6.
Zurück zum Zitat Byl B, Clevenbergh P, Jacobs F, Struelens MJ, Zech F, Kentos A, Thys JP (1999) Impact of infectious diseases specialists and microbiological data on the appropriateness of antimicrobial therapy for bacteremia. Clin Infect Dis 29:60–66PubMedCrossRef Byl B, Clevenbergh P, Jacobs F, Struelens MJ, Zech F, Kentos A, Thys JP (1999) Impact of infectious diseases specialists and microbiological data on the appropriateness of antimicrobial therapy for bacteremia. Clin Infect Dis 29:60–66PubMedCrossRef
7.
Zurück zum Zitat Grace CJ, Lieberman J, Pierce K, Littenberg B (2001) Usefulness of blood culture for hospitalized patients who are receiving antibiotic therapy. Clin Infect Dis 32:1651–1655PubMedCrossRef Grace CJ, Lieberman J, Pierce K, Littenberg B (2001) Usefulness of blood culture for hospitalized patients who are receiving antibiotic therapy. Clin Infect Dis 32:1651–1655PubMedCrossRef
8.
Zurück zum Zitat Munson EL, Diekema DJ, Beekmann SE, Chapin KC, Doern GV (2003) Detection and treatment of bloodstream infection: laboratory reporting and antimicrobial management. J Clin Microbiol 41:495–497PubMedCrossRef Munson EL, Diekema DJ, Beekmann SE, Chapin KC, Doern GV (2003) Detection and treatment of bloodstream infection: laboratory reporting and antimicrobial management. J Clin Microbiol 41:495–497PubMedCrossRef
9.
Zurück zum Zitat Hautala T, Syrjala H, Lehtinen V, Kauma H, Kauppila J, Kujala P, Pietarinen I, Ylipalosaari P, Koskela M (2005) Blood culture gram stain and clinical categorization based empirical antimicrobial therapy of bloodstream infection. Int J Antimicrob Agents 25:329–333PubMedCrossRef Hautala T, Syrjala H, Lehtinen V, Kauma H, Kauppila J, Kujala P, Pietarinen I, Ylipalosaari P, Koskela M (2005) Blood culture gram stain and clinical categorization based empirical antimicrobial therapy of bloodstream infection. Int J Antimicrob Agents 25:329–333PubMedCrossRef
10.
Zurück zum Zitat Finkelstein R, Fusman R, Oren I, Kassis I, Hashman N (2002) Clinical and epidemiologic significance of coagulase-negative Staphylococci bacteremia in a tertiary care University Israeli Hospital. Am J Infect Control 30:21–25PubMedCrossRef Finkelstein R, Fusman R, Oren I, Kassis I, Hashman N (2002) Clinical and epidemiologic significance of coagulase-negative Staphylococci bacteremia in a tertiary care University Israeli Hospital. Am J Infect Control 30:21–25PubMedCrossRef
11.
Zurück zum Zitat Beekmann SE, Diekema DJ, Doern GV (2005) Determining the clinical significance of coagulase-negative Staphylococci isolated from blood cultures. Infect Control Hosp Epidemiol 26:559–566PubMedCrossRef Beekmann SE, Diekema DJ, Doern GV (2005) Determining the clinical significance of coagulase-negative Staphylococci isolated from blood cultures. Infect Control Hosp Epidemiol 26:559–566PubMedCrossRef
12.
Zurück zum Zitat Favre B, Hugonnet S, Correa L, Sax H, Rohner P, Pittet D (2005) Nosocomial bacteremia: clinical significance of a single blood culture positive for coagulase-negative Staphylococci. Infect Control Hosp Epidemiol 26:697–702PubMedCrossRef Favre B, Hugonnet S, Correa L, Sax H, Rohner P, Pittet D (2005) Nosocomial bacteremia: clinical significance of a single blood culture positive for coagulase-negative Staphylococci. Infect Control Hosp Epidemiol 26:697–702PubMedCrossRef
13.
Zurück zum Zitat Chatzinikolaou I, Hanna H, Darouiche R, Samonis G, Tarrand J, Raad I (2006) Prospective study of the value of quantitative culture of organisms from blood collected through central venous catheters in differentiating between contamination and bloodstream infection. J Clin Microbiol 44:1834–1835PubMedCrossRef Chatzinikolaou I, Hanna H, Darouiche R, Samonis G, Tarrand J, Raad I (2006) Prospective study of the value of quantitative culture of organisms from blood collected through central venous catheters in differentiating between contamination and bloodstream infection. J Clin Microbiol 44:1834–1835PubMedCrossRef
14.
Zurück zum Zitat Kassis C, Rangaraj G, Jiang Y, Hachem RY, Raad I (2009) Differentiating culture samples representing coagulase-negative staphylococcal bacteremia from those representing contamination by use of time-to-positivity and quantitative blood culture methods. J Clin Microbiol 47:3255–3260PubMedCrossRef Kassis C, Rangaraj G, Jiang Y, Hachem RY, Raad I (2009) Differentiating culture samples representing coagulase-negative staphylococcal bacteremia from those representing contamination by use of time-to-positivity and quantitative blood culture methods. J Clin Microbiol 47:3255–3260PubMedCrossRef
15.
Zurück zum Zitat Horan TC, Andrus M, Dudeck MA (2008) CDC/NHSN surveillance definition of health care-associated infection and criteria for specific types of infections in the acute care setting. Am J Infect Control 36:309–332PubMedCrossRef Horan TC, Andrus M, Dudeck MA (2008) CDC/NHSN surveillance definition of health care-associated infection and criteria for specific types of infections in the acute care setting. Am J Infect Control 36:309–332PubMedCrossRef
16.
Zurück zum Zitat Freifeld AG, Bow EJ, Sepkowitz KA, Boeckh MJ, Ito JI, Mullen CA, Raad II, Rolston KV, Young JA, Wingard JR (2011) Clinical practice guideline for the use of antimicrobial agents in neutropenic patients with cancer: 2010 update by the infectious diseases society of America. Clin Infect Dis 52:e56–e93PubMedCrossRef Freifeld AG, Bow EJ, Sepkowitz KA, Boeckh MJ, Ito JI, Mullen CA, Raad II, Rolston KV, Young JA, Wingard JR (2011) Clinical practice guideline for the use of antimicrobial agents in neutropenic patients with cancer: 2010 update by the infectious diseases society of America. Clin Infect Dis 52:e56–e93PubMedCrossRef
17.
Zurück zum Zitat Plouffe JF Jr, Martin DR (2004) Re-evaluation of the therapy of severe pneumonia caused by Streptococcus pneumoniae. Infect Dis Clin North Am 18:963–974PubMedCrossRef Plouffe JF Jr, Martin DR (2004) Re-evaluation of the therapy of severe pneumonia caused by Streptococcus pneumoniae. Infect Dis Clin North Am 18:963–974PubMedCrossRef
18.
Zurück zum Zitat Somerville GA, Proctor RA (2009) At the crossroads of bacterial metabolism and virulence factor synthesis in Staphylococci. Microbiol Mol Biol Rev 73:233–248PubMedCrossRef Somerville GA, Proctor RA (2009) At the crossroads of bacterial metabolism and virulence factor synthesis in Staphylococci. Microbiol Mol Biol Rev 73:233–248PubMedCrossRef
Metadaten
Titel
True bacteremias caused by coagulase negative Staphylococcus are difficult to distinguish from blood culture contaminants
verfasst von
M. Rahkonen
S. Luttinen
M. Koskela
T. Hautala
Publikationsdatum
01.10.2012
Verlag
Springer-Verlag
Erschienen in
European Journal of Clinical Microbiology & Infectious Diseases / Ausgabe 10/2012
Print ISSN: 0934-9723
Elektronische ISSN: 1435-4373
DOI
https://doi.org/10.1007/s10096-012-1607-9

Weitere Artikel der Ausgabe 10/2012

European Journal of Clinical Microbiology & Infectious Diseases 10/2012 Zur Ausgabe

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Notfall-TEP der Hüfte ist auch bei 90-Jährigen machbar

26.04.2024 Hüft-TEP Nachrichten

Ob bei einer Notfalloperation nach Schenkelhalsfraktur eine Hemiarthroplastik oder eine totale Endoprothese (TEP) eingebaut wird, sollte nicht allein vom Alter der Patientinnen und Patienten abhängen. Auch über 90-Jährige können von der TEP profitieren.

Niedriger diastolischer Blutdruck erhöht Risiko für schwere kardiovaskuläre Komplikationen

25.04.2024 Hypotonie Nachrichten

Wenn unter einer medikamentösen Hochdrucktherapie der diastolische Blutdruck in den Keller geht, steigt das Risiko für schwere kardiovaskuläre Ereignisse: Darauf deutet eine Sekundäranalyse der SPRINT-Studie hin.

Bei schweren Reaktionen auf Insektenstiche empfiehlt sich eine spezifische Immuntherapie

Insektenstiche sind bei Erwachsenen die häufigsten Auslöser einer Anaphylaxie. Einen wirksamen Schutz vor schweren anaphylaktischen Reaktionen bietet die allergenspezifische Immuntherapie. Jedoch kommt sie noch viel zu selten zum Einsatz.

Therapiestart mit Blutdrucksenkern erhöht Frakturrisiko

25.04.2024 Hypertonie Nachrichten

Beginnen ältere Männer im Pflegeheim eine Antihypertensiva-Therapie, dann ist die Frakturrate in den folgenden 30 Tagen mehr als verdoppelt. Besonders häufig stürzen Demenzkranke und Männer, die erstmals Blutdrucksenker nehmen. Dafür spricht eine Analyse unter US-Veteranen.

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.